Effect of pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on hepatic cholesterol 7α-hydroxylase, acyl-coenzyme A: cholesterol acyltransferase, and bile lipid secretion in the hamster with intact enterohepatic circulation
✍ Scribed by Kozo Hayashi; Mitsuhide Noshiro; Hitoshi Kurushima; Yoshio Kuga; Syu-ichi Nomura; Yoshifumi Ohkura; Harumi Ohtani; Jun-ichi Kurokawa; Kouichi Tanaka; Yuji Yasunobu; Masayuki Kambe; Goro Kajiyama
- Book ID
- 118324605
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 766 KB
- Volume
- 111
- Category
- Article
- ISSN
- 0021-9150
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
3-hydroxy,3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors reduce biliary cholesterol saturation index (CSI) in duodenal bile in hypercholesterolemic patients and might be useful for gallstone dissolution. However, preliminary data suggest that these drugs are not effective in this respect
We investigated hepatic cholesterol homeostasis in four homozygous sitosterolemic subjects from two unrelated families who showed enhanced absorption, diminished removal and increased tissue and plasma concentrations of sitosterol (24-ethyl cholesterol). Measurements of hepatic 3-hydroxy-3-methylglu